Including Blinatumomab for Toddler Leukemia
The immunotherapy blinatumomab improves short-term outcomes when added to straightforward chemotherapy for infants with KMT2A-rearranged acute lymphoblastic leukemia (ALL), in...
Leukemia
The immunotherapy blinatumomab improves short-term outcomes when added to straightforward chemotherapy for infants with KMT2A-rearranged acute lymphoblastic leukemia (ALL), in...
